Renoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuria

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 7, 2012, Pages

  Agarwal, Pramod K ^a   van den Born, Jacob ^a   van Goor, Harry ^a   Navis, Gerjan ^a   Gans, Rijk O B ^a   Bakker, Stephan J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chronic inflammation; Glomerulopathy; Kidney function

Indexed keywords

DESMIN; DRINKING WATER; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINE; PODOCIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DENSITY; CELL INFILTRATION; COMPARATIVE STUDY; CREATININE CLEARANCE; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL RAT; FOCAL GLOMERULOSCLEROSIS; KIDNEY CELL; KIDNEY FUNCTION; MACROPHAGE; MALE; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL PROTECTION;

EID: 84859469430     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00507.2011     Document Type: Article

References (57)

1. Agarwal PK, Hellemons ME, Zelle DM, van Ree RM, van den Born J, Homan van der Heide JJ, Gans RO, van Son WJ, Navis G, Bakker SJ. Smoking is a risk factor for graft failure and mortality after renal transplantation. Am J Nephrol 34: 26-31, 2011.
2. Arany I, Grifoni S, Clark JS, Csongradi E, Maric C, Juncos LA. Chronic nicotine exposure exacerbates acute renal ischemic injury. Am J Physiol Renal Physiol 301: F125-F133, 2011.
3. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53-59, 1991.
4. Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 68: 931-949, 2011.
5. Blanchet MR, Israel-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 169: 903-909, 2004.
6. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462, 2000.
7. Braun N, Schmutzler F, Lange C, Perna A, Remuzzi G, Risler T, Willis NS. Immunosuppressive treatment for focal segmental glomerulo-sclerosis in adults. Cochrane Database Syst Rev CD003233, 2008.
8. Chong IW, Lin SR, Hwang JJ, Huang MS, Wang TH, Hung JY, Paulauskis JD. Expression and regulation of the macrophage inflammatory protein-1 alpha gene by nicotine in rat alveolar macrophages. Eur Cytokine Netw 13: 242-249, 2002.
9. Cui WY, Li MD. Nicotinic modulation of innate immune pathways via alpha7 nicotinic acetylcholine receptor. J Neuroimmune Pharmacol 5: 479-488, 2010.
10. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851, 2005.
11. Duffield JS. Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30: 234-254, 2010.
12. El-Gowilly SM, Ghazal AR, Gohar EY, El-Mas MM. Exacerbation by nicotine of the cyclosporine A-induced impairment of beta-adrenoceptor-mediated renal vasodilation in rats. Clin Exp Pharmacol Physiol 35: 1164-1171, 2008.
13. El-Mas MM, El-Gowilly SM, Gohar EY, Ghazal AR. Pharmacological characterization of cellular mechanisms of the renal vasodilatory effect of nicotine in rats. Eur J Pharmacol 588: 294-300, 2008.
14. Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, Grando SA, Kawashima K. Enhanced serum antigen-specific IgG1 and proin-flammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J Neuroimmunol 189: 69-74, 2007.
15. Hamming I, Navis G, Kocks MJ, van Goor H. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol 209: 129-139, 2006.
16. Hua P, Feng W, Ji S, Raij L, Jaimes EA. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers. Am J Physiol Renal Physiol 299: F732-F739, 2010.
17. Jatlow P, Toll BA, Leary V, Krishnan-Sarin S, O'Malley SS. Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence. Drug Alcohol Depend 98: 203-209, 2008.
18. Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int 62: 2301-2310, 2002.
19. Korbet SM. The treatment of primary focal segmental glomerulosclerosis. Ren Fail 22: 685-696, 2000.
20. Kramer AB, Laverman GD, van Goor H, Navis G. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage. J Pathol 201: 160-167, 2003.
21. Mabley JG, Pacher P, Southan GJ, Salzman AL, Szabo C. Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther 300: 876-881, 2002.
22. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A. Pathophysiologicimplications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168: 42-54, 2006.
23. Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliar-dini E, Remuzzi G, Remuzzi A. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol 174: 797-807, 2009.
24. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78: 303-309, 2010.
25. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsarinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372: 547-553, 2008.
26. Nathan CF. Secretory products of macrophages. J Clin Invest 79: 319-326, 1987.
27. Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR. Cigarette smoke condensate aggravates renal injury in the renal ablation model. Kidney Int 61: 2090-2098, 2002.
28. Orth SR, Ritz E. The renal risks of smoking: an update. Curr Opin Nephrol Hypertens 11: 483-488, 2002.
29. Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis 207: 534-540, 2009.
30. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, Pechacek TF, Howard G, American Heart Association Council on Cardiovascular Nursing. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122: 1520-1544, 2010.
31. Rani R, Smulian AG, Greaves DR, Hogan SP, Herbert DR. TGF-beta limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol 2011.
32. Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am J Kidney Dis 34: 626-632, 1999.
33. Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 69: 1124-1130, 2006.
34. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67: 572-579, 1992.
35. Ritz E, Benck U, Franek E, Keller C, Seyfarth M, Clorius J. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9: 1798-1804, 1998.
36. Rodriguez-Iturbe B, Garcia G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 116: c81-8, 2010.
37. Russell MA, Merriman R, Stapleton J, Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br Med J (Clin Res Ed) 287: 1782-1785, 1983.
38. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J 2: 231-235, 1979.
39. Sadis C, Teske G, Stokman G, Kubjak C, Claessen N, Moore F, Loi P, Diallo B, Barvais L, Goldman M, Florquin S, Le MA. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One 2: e469, 2007.
40. Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 8: 253-261, 1983.
41. Silagy C, Mant D, Fowler G, Lodge M. The effectiveness of nicotine replacement therapies in smoking cessation. Online J Curr Clin Trials Doc No 113: 7906, 1994.
42. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139-142, 1994.
43. Smith GD. Smoking and lung cancer: causality, Cornfield and an early observational meta-analysis. Int J Epidemiol 38: 1169-1171, 2009.
44. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20: 2305-2313, 2009.
45. Sykes AP, Brampton C, Klee S, Chander CL, Whelan C, Parsons ME. An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res 49: 311-319, 2000.
46. Takahashi HK, Iwagaki H, Hamano R, Yoshino T, Tanaka N, Nishi-bori M. Effect of nicotine on IL-18-initiated immune response in human monocytes. J Leukoc Biol 80: 1388-1394, 2006.
47. van Es N, Schulz A, Ijpelaar D, van der Wal A, Kuhn K, Schutten S, Kossmehl P, Nyengaard JR, de Heer E, Kreutz R. Elimination of severe albuminuria in aging hypertensive rats by exchange of 2 chromosomes in double-consomic rats. Hypertension 58: 219-224, 2011.
48. Waanders F, Rienstra H, Boer MW, Zandvoort A, Rozing J, Navis G, van Goor H, Hillebrands JL. Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats. Am J Physiol Renal Physiol 296: F1072-F1079, 2009.
49. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221, 2004.
50. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388, 2003.
51. Wang X, Yang Z, Xue B, Shi H. Activation of the cholinergic antiin-flammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology 152: 836-846, 2011.
52. Weisser SB, McLarren KW, Voglmaier N, van Netten-Thomas CJ, Antov A, Flavell RA, Sly LM. Alternative activation of macrophages by IL-4 requires SHIP degradation. Eur J Immunol 2011.
53. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 6: 300, 2006.
54. Yeboah MM, Xue X, Duan B, Ochani M, Tracey KJ, Susin M, Metz CN. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 74: 62-69, 2008.
55. Yeboah MM, Xue X, Javdan M, Susin M, Metz CN. Nicotinic acetyl-choline receptor expression and regulation in the rat kidney after ischemia-reperfusion injury. Am J Physiol Renal Physiol 295: F654-F661, 2008.
56. Zhang QL, Baumert J, Ladwig KH, Wichmann HE, Meisinger C, Doring A. Association of daily tar and nicotine intake with incident myocardial infarction: results from the population-based MONICA/KORA Augsburg Cohort Study 1984 -2002. BMC Public Health 11: 273, 2011.
57. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 105: 15896-15901, 2008.